References
- WHO. Coronavirus disease (COVID-2019) situation reports. 2020.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Access on December 27, 2020.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and
risk factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: a retrospective cohort study. Lancet. 2020;395:1054-1062
- Ayten O, Saylan B. Retrospective analysis of severe COVID-19 pneumonia
patients treated with lopinavir/ritonavir: A comparison with survivor
and non-survivor patients. Southern African Journal of Infectious
Diseases;2020; 35: 2312-0053 DOI:
https://doi.org/10.4102/sajid.v35i1.233
- Saklayen M.G, The Global Epidemic of the Metabolic Syndrome . Review
Curr Hypertens Rep . 2018 Feb 26;20(2):12.
- Hoffman E.L, Von Wald T, Hansen K. The metabolic syndrome . South
Dakota Medicine. 2015; Spec No:24-8.
- Rottoli M, Bernante P, Belvedere A, et al. Obesity is one of the
strongest risk factor for respiratory failure and death in COVID-19.
Patients: A Retrospective Multicentric Cohort Study, 2020
- Grundy S.M, Cleeman J.I, Daniels S.R, Eckel R.H, Franklin B.A, Gordon
D.J et al. Diagnosis and management of the metabolic syndrome: an
American Heart Association/National Heart, Lung, and Blood Institute
Scientific Statement. Circulation. 2005;112(17):2735-52.
- COVID-19 (SARS-CoV-2 Infection) Guide of Ministry of Health of
Republic of Turkey, April 14, 2020
- Chang Y, Yu C, Chang S, Galvin JR, Liu H, Hsiao C, et al. Pulmonary
sequelae in convalescent patients after severe acute respiratory
syndrome: evaluation with thin-section CT. Radiology
2005;236(3):1067–75
- Norman, G. (2010). Likert scales, levels of measurement and the
“laws” of statistics. Advances in Health Sciences Education, 15 (5),
625-632
- Wu Z, McGoogan JM. Characteristics of and important lessons from the
coronavirus disease 2019 (COVID-19) outbreak in China: summary of a
report of 72,314 cases from the Chinese Center for Disease Control and
Prevention. JAMA. 2020;323:1239–1242.
- Xie J, Zu Y, Alkhatib A, Pham T.T, Gill F, Jang A et al. Metabolic
Syndrome and COVID-19 Mortality Among Adult Black Patients in New
Orleans. Diabetes Care. 2020 Aug 25;44(1):188-193.
- Lohia P, Kapur S, Benjaram S, Pandey A, Mir T, Seyoum B. Metabolic
Syndrome and clinical outcomes in patients infected with COVID19: Does
age, sex and race of the patient with Metabolic Syndrome matter? J
Diabetes. 2021 Jan 16. doi: 10.1111/1753-0407.13157. Online ahead of
print.
- Rubel A.A, Chong P.L, Abdullah M.S, Asli R, Momin R.N, Mani B.I et al.
Lipemic serum in patients with Coronavirus Disease 2019 (COVID‐19)
undergoing treatment. J Med Virol. 2020 Jun 2 : 10.1002/ jmv. 25942.
doi: 10.1002/jmv.25942 [Epub ahead of print]
- Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F et al.
The metabolic syndrome, incidence of diabetes and mortality among the
elderly: The Italian Longitudinal Study of Aging. J Gerontol A Biol
Sci Med Sci. 2006 May;61(5):505-10
- Hildrum B, Mykletun A, Dahl AA, Midthjell K. Metabolic syndrome and
risk of mortality in middle-aged versus elderly individuals: the
Nord-Trøndelag Health Study (HUNT). Diabetologia . 2009
Apr;52(4):583-90.
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y et al. Risk factors for
severity and mortality in adult COVID-19 inpatients in Wuhan. J
Allergy Clin Immunol. 2020 Jul;146(1):110-118.
- Albitar O, Ballouze R, Ooi J.P, Ghadzi S.M.S. Risk factors for
mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020
Aug;166:108293.
- Wartz H, Waschki B, Kirsten A, Müller C, Kretschmar G, Meyer T at al .
The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD:
Frequency and Associated Consequences for Systemic Inflammation and
Physical Inactivity. Chest. 2009 October: 136; 4;1039-1046
- Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic
syndrome: an intriguing association Internal and Emergency Medicine
2013:8;283–289
- Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et
al. ISARIC4C investigators. Features of 20 133 UK patients in hospital
with covid-19 using the ISARIC WHO clinical characterisation protocol:
prospective observational cohort study. BMJ. 2020;369:m1985.
- Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et
al. COVID-19 Lombardy ICU Network. Risk factors associated with
mortality among patients with COVID-19 in intensive care units in
Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355.
- Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al.
Prevalence of co-morbidities and their association with mortality in
patients with COVID-19: a systematic review and meta-analysis Diabetes
Obes Metab 2020 Jun 23 : 10.1111/dom.14124. doi: 10.1111/dom.14124
[Epub ahead of print]
- Nakajima K. Serious Conditions in COVID-19 Accompanied With a Feature
of Metabolic Syndrome. J Clin Med Res. 2020 May; 12(5):
273–275.Leisegang K, Henkel R, Agarwal A. Obesity and metabolic
syndrome associated with systemic inflammation and the impact on the
male reproductive system. Am J Reprod Immunol. 2019;82(5):e13178
- Chocair P.R, Neves P.D.M.M, Pereira L.V.B, Mohrbacher S, Oliveira E.S,
Nardotto L.L et al. Covid-19 and Metabolic Syndrome . Letters to
editor. Rev Assoc Med Bras. 2020; 66(7):871-875